Canada received the first consignment of 500,000 AstraZeneca's "Made-in-India" CoviShield coronavirus vaccines on March 4.
It is produced at the Pune-based Serum Institute of India. India will be sending a tranche of 1.5 million more doses to Canada.
This comes as another 3,221 people have tested positive for the novel coronavirus, pushing the total number of cases in Canada to 896,744 on Wednesday.
Provincial health authorities also confirmed 31 more people have died after contracting the virus, meaning to date, the virus has claimed 22,335 lives in Canada.
Earlier this month, PM Modi spoke to his Canadian counterpart Justin Trudeau and assured him that India will do its best to support Canada's Covid-19 vaccination efforts.
Expressing his appreciation, the Canadian Prime Minister said that if the world managed to conquer COVID-19, "it would be significantly because of India's tremendous pharmaceutical capacity, and Prime Minister Modi's leadership in sharing this capacity with the world".
The Prime Minister thanked PM Trudeau for his sentiments.
Adar Poonawalla, CEO of Serum Institute of India earlier this month said that "Dear Hon'ble PM @JustinTrudeau, I thank you for your warm words towards India and its vaccine industry. As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!"
A few days ago, speaking at the virtual India-Sweden summit, PM Modi had said that 'Made-in-India' vaccines have been supplied to over 50 countries so far. He had also said that New Delhi has plans to supply vaccines to more countries in the months to come.
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Never miss a story! Stay connected and informed with Mint.
our App Now!!